McKesson Corporation $MCK Shares Sold by Dana Investment Advisors Inc.

Dana Investment Advisors Inc. reduced its position in shares of McKesson Corporation (NYSE:MCK) by 3.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 22,404 shares of the company’s stock after selling 868 shares during the period. Dana Investment Advisors Inc.’s holdings in McKesson were worth $18,378,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in MCK. GGM Financials LLC acquired a new position in shares of McKesson during the third quarter worth $25,000. State of Wyoming acquired a new position in shares of McKesson during the second quarter worth $29,000. Hopwood Financial Services Inc. acquired a new position in shares of McKesson during the third quarter worth $31,000. Vermillion & White Wealth Management Group LLC acquired a new position in shares of McKesson during the third quarter worth $33,000. Finally, Board of the Pension Protection Fund acquired a new position in shares of McKesson during the fourth quarter worth $33,000. 85.07% of the stock is owned by institutional investors and hedge funds.

McKesson Trading Up 1.7%

Shares of NYSE:MCK opened at $759.82 on Friday. The company has a fifty day simple moving average of $854.83 and a 200 day simple moving average of $857.22. The firm has a market cap of $91.33 billion, a PE ratio of 19.75, a price-to-earnings-growth ratio of 1.11 and a beta of 0.35. McKesson Corporation has a 12-month low of $637.00 and a 12-month high of $999.00.

McKesson (NYSE:MCK) last issued its quarterly earnings results on Thursday, May 7th. The company reported $11.69 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $11.56 by $0.13. The business had revenue of $96.30 billion during the quarter, compared to analyst estimates of $101.35 billion. McKesson had a net margin of 1.18% and a negative return on equity of 345.35%. The business’s revenue was up 6.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $10.12 earnings per share. McKesson has set its FY 2027 guidance at 43.800-44.600 EPS. As a group, equities research analysts forecast that McKesson Corporation will post 44.29 EPS for the current fiscal year.

McKesson Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 1st. Shareholders of record on Monday, June 1st will be paid a dividend of $0.82 per share. The ex-dividend date is Monday, June 1st. This represents a $3.28 annualized dividend and a yield of 0.4%. McKesson’s payout ratio is presently 8.53%.

Insider Buying and Selling at McKesson

In other McKesson news, Director Maria Martinez sold 349 shares of the business’s stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $939.87, for a total transaction of $328,014.63. Following the completion of the sale, the director owned 301 shares in the company, valued at $282,900.87. The trade was a 53.69% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Michele Lau sold 2,725 shares of the business’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $990.00, for a total transaction of $2,697,750.00. Following the sale, the executive vice president owned 3,247 shares of the company’s stock, valued at approximately $3,214,530. The trade was a 45.63% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 3,264 shares of company stock worth $3,205,315 over the last 90 days. Insiders own 0.08% of the company’s stock.

Analyst Upgrades and Downgrades

MCK has been the topic of a number of recent research reports. William Blair initiated coverage on shares of McKesson in a research report on Tuesday, April 28th. They set an “outperform” rating on the stock. Leerink Partners reissued an “outperform” rating and set a $1,085.00 target price on shares of McKesson in a research report on Thursday, March 5th. UBS Group boosted their target price on shares of McKesson from $1,000.00 to $1,050.00 and gave the stock a “buy” rating in a research report on Friday, May 8th. Raymond James Financial set a $970.00 target price on shares of McKesson in a research report on Thursday, March 5th. Finally, TD Cowen lifted their price target on shares of McKesson from $1,000.00 to $1,012.00 and gave the stock a “buy” rating in a research note on Thursday, February 5th. Fourteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $968.87.

McKesson Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.